2seventy bio, Inc. - Common Stock (NQ:TSVT)

5.000 UNCHANGED

Last Price Updated: 4:00 PM EDT, May 12, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about 2seventy bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

2seventy Bio's Cost Cuts Prudent But Analyst Says It Induces Lower Confidence In Lead Product ↗

September 13, 2023

Guggenheim Partners downgraded 2seventy Bio Inc (NASDAQ: TSVT) to Neutral from Buy and

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2023 ↗

September 13, 2023

Via Benzinga

The Latest Analyst Ratings for 2seventy bio ↗

September 12, 2023

Via Benzinga

Analyst Expectations for 2seventy bio's Future ↗

August 15, 2023

Via Benzinga

Where 2seventy bio Stands With Analysts ↗

July 28, 2023

Via Benzinga

2seventy bio Announces Strategic Restructuring to Prioritize Growth of Abecma, Streamline Pipeline Advancement and Preserve Financial Runway

September 12, 2023

From 2seventy bio, Inc.

Via Business Wire

2seventy bio and JW Therapeutics Announce Intent To Expand Strategic Partnership to Accelerate the Research and Development of T Cell-based Immunotherapies and Autoimmune Therapies

September 12, 2023

From 2seventy bio

Via Business Wire

2seventy bio to Participate in the 2023 Morgan Stanley Global Healthcare Conference

September 06, 2023

From 2seventy bio, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Monday ↗

September 11, 2023

Monday's session saw 175 companies set new 52-week lows.

Via Benzinga

Around $3.5M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying ↗

August 17, 2023

Although U.S. stocks closed lower on Wednesday, there were a few notable insider trades.

Via Benzinga

Paysafe, Taylor Devices, SomaLogic And Other Big Stocks Moving Higher On Tuesday ↗

August 15, 2023

U.S. stocks traded lower, with the Dow Jones falling around 300 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Why PhenomeX Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

August 15, 2023

Gainers Novo Integrated Sciences, Inc. (NASDAQ: NVOS) jumped 85.4% to $0.1267 after the company and Farm 7 Group announced a joint venture for Kenya Agricultural Cooperative Project.

Via Benzinga

2seventy bio Reports Second Quarter Financial Results and Recent Operational Progress

August 14, 2023

From 2seventy bio, Inc.

Via Business Wire

Earnings Scheduled For August 14, 2023 ↗

August 14, 2023

Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

August 09, 2023

On Wednesday, 155 companies set new 52-week lows.

Via Benzinga

2seventy bio to Report Second Quarter 2023 Financial Results on August 14, 2023

August 08, 2023

From 2seventy bio, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Wednesday ↗

August 02, 2023

During Wednesday's trading, 103 companies set new 52-week lows.

Via Benzinga

2seventy bio to Participate in 2023 Wedbush PacGrow Healthcare Conference

August 01, 2023

From 2seventy bio

Via Business Wire

Stocks That Hit 52-Week Lows On Tuesday ↗

August 01, 2023

On Tuesday, 46 stocks hit new 52-week lows.

Via Benzinga

Arcellx's Lead Product Candidate Hit By FDA Clinical Hold For Multiple Myeloma, Stock Falls ↗

June 20, 2023

The FDA has put a clinical hold on Arcellx Inc's (NASDAQ: ACLX) iMMagine-1 Phase 2 clinical program for CART-ddBCMA investigational new drug for

Via Benzinga

Cancer Drug Trials Put On Hold After Patients Died ↗

June 17, 2023

Recent reports from two drug companies that had been conducing separate clinical trials to evaluate cancer treatments reveal that the trials were halted due to the deaths of six participants, including...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

July 28, 2023

Friday's session saw 59 companies set new 52-week lows.

Via Benzinga

2seventy Bio Pauses Pediatric Blood Cancer Trial After Patient Death, Stock Plunges ↗

June 14, 2023

2seventy Bio Inc (NASDAQ: TSVT) announced that the Phase 1 trial of the PLAT-08 study of SC-DARIC33 in Acute Myeloid Leukemia (AML), has been paused by Seattle Children's, the company's partner and...

Via Benzinga

2seventy Bio Stock Crumbles After A Patient Dies In Its Pediatric Cancer Study ↗

June 14, 2023

The company is investigating whether the death is tied to the experimental drug.

Via Investor's Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2023 ↗

July 28, 2023

Via Benzinga

2seventy bio Announces Clinical Study Pause of PLAT-08 Trial of SC-DARIC33 in Acute Myeloid Leukemia

June 14, 2023

From 2seventy bio, Inc.

Via Business Wire

2seventy bio to Participate in Upcoming Investor Conference

June 07, 2023

From 2seventy bio, Inc.

Via Business Wire

2seventy bio Presents Late-Breaking Results for SC-DARIC33, an Investigational CD33-Targeting CAR T in Pediatric and Young Adults with Relapsed or Refractory Acute Myeloid Leukemia

May 19, 2023

From 2seventy bio

Via Business Wire

2seventy bio Presents Broad Range of New Data Highlighting Novel Approaches Across its Cell Therapies Portfolio

May 17, 2023

From 2seventy bio, Inc.

Via Business Wire

Benzinga Pro's Top 5 Stocks To Watch For Friday, May 12, 2023: CMCSA, KR, ON, TSVT, CMND ↗

May 12, 2023

Comcast (CMCSA) - The parent company of NBCUniversal. One of Friday's most-discussed stories stemmed from a tweet by Elon Musk he had found a new exec to file the chief exec role at Twitter.

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.